GlassScriptPhysician profile
John Abraham Thomas
NPI 1710093976
$300,299.84
in general payments reported to CMS, 2019-2025
14 companies · $294K in 2025
The $294K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $2,880 · 2021: $141 · 2022: $1,325 · 2023: $326 · 2024: $191 · 2025: $294K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $294K · Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $294,384.97 |
| Food and Beverage | $569.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $294,418.58 | 2023-2025 | Modulus, Proximal Tibia Plate |
| Stryker Corporation | $4,108.89 | 2019-2024 | Mako |
| Alphatec Spine, INC | $1,324.87 | 2022 | |
| Bioventus LLC | $113.19 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Lima USA, INC. | $88.47 | 2023 | Lantern Surgical Assistant |
| Amgen INC. | $69.82 | 2023-2025 | Evenity, Krystexxa, Prolia |
| Wright Medical Technology, INC. | $46.44 | 2020 | |
| Innovation Technologies INC | $24.78 | 2024 | Irrisept |
| Abbott Laboratories | $20.30 | 2024 | Proclaim |
| Electronic Waveform Lab, INC. | $19.47 | 2024 | |
| Molnlycke Health Care US, LLC | $18.61 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Baudax Bio INC. | $15.88 | 2020 | |
| Depuy Synthes Sales INC. | $15.63 | 2021 | |
| Abbvie INC. | $14.91 | 2023 | Teflaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.